Payment overview · 2025
General Payments
$41.86
2 reported records · 1 companies
Healthcare provider profile · identity verified
John E Hortareas, DO
Allopathic & Osteopathic Physicians|Internal Medicine · PHOENIX, AZ · NPI 1376536193
Verified facts
What the public records show
CMS Open Payments records show John E Hortareas, DO received $41.86 in general payments during 2025 across 2 reported records.
Abbott Laboratories accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $41.86 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $41.86 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OCTRODE Normalized: octrode |
Device | Abbott Laboratories | $24.22 | 1 | 2025 |
Source payment records
|
|||||
| PROCLAIM Normalized: proclaim |
Device | Abbott Laboratories | $17.64 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 478 | 86 |
| Gabapentin | Gabapentin | 377 | 79 |
| Eliquis | Apixaban | 348 | 56 |
| Levothyroxine Sodium | Levothyroxine Sodium | 276 | 46 |
| Amlodipine Besylate | Amlodipine Besylate | 273 | 53 |
| Furosemide | Furosemide | 259 | 46 |
| Metoprolol Tartrate | Metoprolol Tartrate | 220 | 50 |
| Trazodone Hcl | Trazodone Hcl | 209 | 39 |
| Donepezil Hcl | Donepezil Hcl | 190 | 33 |
| Potassium Chloride | Potassium Chloride | 185 | 44 |
| Losartan Potassium | Losartan Potassium | 163 | 30 |
| Tamsulosin Hcl | Tamsulosin Hcl | 158 | 24 |
| Pantoprazole Sodium | Pantoprazole Sodium | 156 | 40 |
| Lisinopril | Lisinopril | 148 | 30 |
| Metformin Hcl | Metformin Hcl | 148 | 24 |
| Sertraline Hcl | Sertraline Hcl | 148 | 33 |
| Omeprazole | Omeprazole | 140 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 126 | 33 |
| Baclofen | Baclofen | 123 | 19 |
| Prednisone | Prednisone | 123 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 116 | 34 |
| Myrbetriq | Mirabegron | 116 | suppressed |
| Mirtazapine | Mirtazapine | 112 | 26 |
| Xarelto | Rivaroxaban | 102 | 12 |
| Carvedilol | Carvedilol | 99 | 24 |
| Divalproex Sodium | Divalproex Sodium | 95 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 27 |
| Buspirone Hcl | Buspirone Hcl | 86 | 16 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 83 | 45 |
| Fluticasone Propionate | Fluticasone Propionate | 73 | 30 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 70 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 14 |
| Simvastatin | Simvastatin | 68 | 12 |
| Ondansetron Odt | Ondansetron | 67 | 37 |
| Montelukast Sodium | Montelukast Sodium | 64 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 61 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 60 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 58 | 14 |
| Lactulose | Lactulose | 57 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 56 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 55 | 20 |
| Latanoprost | Latanoprost | 55 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 54 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 54 | 13 |
| Levetiracetam | Levetiracetam | 53 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 53 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 52 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 51 | 15 |
| Ozempic | Semaglutide | 48 | suppressed |
| Topiramate | Topiramate | 47 | suppressed |
| Hydrocortisone | Hydrocortisone | 44 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 42 | 12 |
| Celecoxib | Celecoxib | 41 | suppressed |
| Allopurinol | Allopurinol | 40 | suppressed |
| Aripiprazole | Aripiprazole | 40 | suppressed |
| Risperidone | Risperidone | 40 | suppressed |
| Memantine Hcl | Memantine Hcl | 39 | suppressed |
| Spironolactone | Spironolactone | 39 | 12 |
| Famotidine | Famotidine | 38 | 13 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 38 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 38 | 21 |
| Bumetanide | Bumetanide | 37 | 13 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 37 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 36 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 36 | 17 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 35 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 35 | suppressed |
| Sucralfate | Sucralfate | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 34 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 15 |
| Ezetimibe | Ezetimibe | 33 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 18 |
| Nystatin | Nystatin | 32 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 31 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 29 | suppressed |
| Meloxicam | Meloxicam | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | suppressed |
| Finasteride | Finasteride | 28 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 28 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 27 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 27 | suppressed |
| Multaq | Dronedarone Hcl | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 20 |
| Insulin Lispro | Insulin Lispro | 25 | suppressed |
| Sulfasalazine | Sulfasalazine | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Lovastatin | Lovastatin | 24 | suppressed |
| Nifedipine Er | Nifedipine | 24 | suppressed |
| Primidone | Primidone | 24 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 24 | suppressed |
| Permethrin | Permethrin | 23 | 21 |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 22 | suppressed |
| Fluconazole | Fluconazole | 22 | 11 |
| Jardiance | Empagliflozin | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Azithromycin | Azithromycin | 21 | 14 |
| Budesonide | Budesonide | 21 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 21 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 21 | 12 |
| Movantik | Naloxegol Oxalate | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Humulin R | Insulin Regular, Human | 20 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | suppressed |
| Calcitriol | Calcitriol | 19 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 19 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Humalog | Insulin Lispro | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | suppressed |
| Trospium Chloride | Trospium Chloride | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 15 | suppressed |
| Acetic Acid | Acetic Acid | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 14 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Repatha Syringe | Evolocumab | 13 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Cephalexin | Cephalexin | 12 | suppressed |
| Glucagon Emergency Kit | Glucagon | 12 | suppressed |
| Zonisamide | Zonisamide | 12 | suppressed |
| Brilinta | Ticagrelor | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Lansoprazole | Lansoprazole | 11 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 11 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $41.86 · 2 records | Abbott Laboratories | OCTRODE, PROCLAIM | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error